Thrombopoietic compounds
Patent Number: 6835809
Date of First Priority Issue: Friday October 23rd, 1998
Date Issued: Tuesday December 28th, 2004
Assignee: Amgen Inc. (Thousand Oaks, CA)
Inventors: Liu, Chuan-Fa (Longmont, CO); Feige, Ulrich (Newbury Park, CA); Cheetham, Janet C. (Montecito, CA)
From Class: Expansion
Comments: No comments
This patent covers a peptide that stimulates stem cells to differentiate into the megakaryocytic lineage. This patent is useful for acceleration of platelet recovery after chemotherapy, radiation therapy, or bone marrow transplant. Since thrombopoietin stimulates early stem cells to self-renew, it may be interesting to see if this peptide also has similar activities.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.